ARMISTICE CAPITAL, LLC - NOVELION THERAPEUTICS INC ownership

NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 68 filers reported holding NOVELION THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of NOVELION THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$5,494,000
-19.6%
1,856,0000.0%0.33%
-26.0%
Q2 2018$6,830,000
+5.1%
1,856,0000.0%0.45%
-10.3%
Q1 2018$6,496,000
+12.2%
1,856,0000.0%0.50%
-13.9%
Q4 2017$5,791,000
-55.6%
1,856,0000.0%0.58%
-62.5%
Q3 2017$13,048,000
-23.7%
1,856,000
+0.2%
1.54%
-29.5%
Q2 2017$17,094,000
-14.1%
1,852,0000.0%2.18%
-46.9%
Q1 2017$19,890,000
+66.4%
1,852,000
+30.4%
4.11%
+45.2%
Q4 2016$11,956,0001,420,0002.83%
Other shareholders
NOVELION THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 1,800,000$1,404,0002.63%
Stonepine Capital Management, LLC 491,096$383,0000.26%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 918,342$716,0000.05%
KNOTT DAVID M 109,135$85,0000.04%
EdgePoint Investment Group Inc. 2,831,555$2,209,0000.02%
Yakira Capital Management, Inc. 36,428$28,0000.01%
FRANKLIN STREET ADVISORS INC /NC 46,000$36,0000.01%
GEODE CAPITAL MANAGEMENT, LLC 85,409$66,0000.00%
FARMERS & MERCHANTS INVESTMENTS INC 191$00.00%
MILLENNIUM MANAGEMENT LLC 37,717$29,0000.00%
View complete list of NOVELION THERAPEUTICS INC shareholders